Search Results - Can-Ming Chen
- Showing 1 - 3 results of 3
-
1
-
2
-
3
ER-poor and HER2-positive: a potential subtype of breast cancer to avoid axillary dissection in node positive patients after neoadjuvant chemo-trastuzumab therapy. by Jian-Wei Li, Miao Mo, Ke-da Yu, Can-Ming Chen, Zhen Hu, Yi-Feng Hou, Gen-Hong Di, Jiong Wu, Zhen-Zhou Shen, Zhi-Ming Shao, Guang-Yu Liu
Published in PLoS ONE (2014-01-01)Get full text
Article
